Skip to main content
. 2019 Aug 10;23(10):6646–6657. doi: 10.1111/jcmm.14537

Figure 6.

Figure 6

5‐Aza‐dC + TSA + sunitinib co‐treatment group suppressed tumour growth in vivo. A‐C, Tumour growth was inhibited in 5‐Aza‐dC treatment group and TSA treatment group and co‐treatment group displayed more obvious trend. *P < 0.05, ** P < 0.01, compared with the sunitinib group. D‐E, The concentration of ki67 was decreased in 5‐Aza‐dC treatment group and TSA treatment group and co‐treatment group displayed more obvious trend. *P < 0.05, ** P < 0.01, compared with the sunitinib group